Lars Hansen

Medicine & Life Sciences

1. Mutation 100%
2. Glycosylation 95%
3. Genes 76%
4. Polysaccharides 60%
5. Glycosyltransferases 53%
6. UDP-N-acetylgalactosamine polypeptide N-acetylgalactosaminyltransferase 6 46%
7. Cataract 44%
8. polypeptide N-acetylgalactosaminyltransferase 42%
9. Galactosyltransferases 37%
10. Missense Mutation 36%
11. Uridine Diphosphate 35%
12. Phenotype 34%
13. Congenital Disorders of Glycosylation 34%
14. Microcephaly 30%
15. LDL Receptors 29%
16. Congenital primary aphakia 28%
17. Trichilemmal Cyst 1 27%
18. Laurin-Sandrow syndrome 26%
19. Gene Targeting 26%
20. polyalanine 26%
21. Patterson Stevenson syndrome 25%
22. Intellectual Disability 23%
23. Mucins 23%
24. Exons 23%
25. Autosomal Dominant Cataract 22%
26. Kufor-Rakeb syndrome 21%
27. Oculocutaneous albinism type 2 21%
28. Gene Editing 21%
29. Lenses 21%
30. Cleidocranial Dysplasia 20%
31. Autosomal Dominant Optic Atrophy 20%
32. CHO Cells 20%
33. Peptides 20%
34. Albinism 19%
35. Eye Color 19%
36. Genome-Wide Association Study 19%
37. Introns 19%
38. Glycoproteins 18%
39. Ligands 17%
40. Guide RNA 17%
41. Ants 17%
42. Nonsense Codon 16%
43. Proteoglycans 16%
44. Glycosylphosphatidylinositols 16%
45. Retinoic Acid Receptors 16%
46. Enzymes 16%
47. Catenins 15%
48. oxidized low density lipoprotein 15%
49. Aphakia 15%
50. Extremities 15%